Literature DB >> 31432355

Choroidal thickness in keratoconus.

Burak Bilgin1, Ayse Sevgi Karadag2.   

Abstract

PURPOSE: Keratoconus is an ectatic eye disease characterized by progressive thinning and steepening of the cornea which leads to irregular astigmatism and visual function loss. Determination of choroidal thickness in keratoconus patients may help us to better understand and manage the keratoconus disease. Choroidal thickness may be a potential marker for disease activity in keratoconus patients. In this study, we aimed to determine choroidal thickness in keratoconus patients and compare the results with the age-matched control group.
METHODS: This is a prospective study with a control group. Keratometry and thinnest corneal thickness was measured and recorded in keratoconus patients. Choroidal thickness of all subjects was measured using an optical coherence tomography device (Spectralis OCT, version 6.0, Heidelberg Engineering, Germany) with an enhanced depth imaging mode without pupil dilation. Mean choroidal thickness of keratoconus patients was compared with healthy subjects.
RESULTS: One hundred and sixty eyes of 80 healthy subjects and 160 eyes of 80 keratoconus patients were included in the study. Mean thinnest corneal thickness of the keratoconus patients was 449.7 ± 3.2 microns. Mean corneal keratometry value and cylindrical refraction error in the keratoconus patients were 53.2 ± 0.2 and 3.3 ± 0.1 diopters, respectively. Mean choroidal thickness was 363.9 ± 59.8 and 328.4 ± 67.2 microns in keratoconus patients and healthy subjects, respectively. There was a very significant difference between keratoconus patients and healthy subjects in terms of choroidal thickness (P = 0.000). There was not a statistically significant correlation between choroidal thickness and thinnest corneal thickness in keratoconus patients (P = 0.814).
CONCLUSION: Choroidal thickness was found to be increased in keratoconus patients. Choroidal thickness could potentially become a new clinical marker for disease activity in keratoconus patients.

Entities:  

Keywords:  Choroidal thickness; Corneal thickness; Keratoconus; Keratometry; Optical coherence tomography

Year:  2019        PMID: 31432355     DOI: 10.1007/s10792-019-01156-y

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  31 in total

1.  Enhanced depth imaging spectral-domain optical coherence tomography.

Authors:  Richard F Spaide; Hideki Koizumi; Maria C Pozzoni; Maria C Pozonni
Journal:  Am J Ophthalmol       Date:  2008-07-17       Impact factor: 5.258

Review 2.  Keratoconus: an inflammatory disorder?

Authors:  V Galvis; T Sherwin; A Tello; J Merayo; R Barrera; A Acera
Journal:  Eye (Lond)       Date:  2015-05-01       Impact factor: 3.775

3.  The effect of head tilt on the measurements of retinal nerve fibre layer and macular thickness by spectral-domain optical coherence tomography.

Authors:  Young Hoon Hwang; Jong Yeon Lee; Yong Yeon Kim
Journal:  Br J Ophthalmol       Date:  2011-02-11       Impact factor: 4.638

4.  Changes in subfoveal choroidal thickness associated with uveitis activity in patients with Behçet's disease.

Authors:  Sho Ishikawa; Manzo Taguchi; Tadashi Muraoka; Yutaka Sakurai; Takayuki Kanda; Masaru Takeuchi
Journal:  Br J Ophthalmol       Date:  2014-06-17       Impact factor: 4.638

5.  Evaluation of choroidal thickness in psoriasis using optical coherence tomography.

Authors:  Fatih Mehmet Türkcü; Alparslan Şahin; Harun Yüksel; Meltem Akkurt; Derya Uçmak; Yasin Çınar; Adnan Yıldırım; İhsan Çaça
Journal:  Int Ophthalmol       Date:  2016-03-08       Impact factor: 2.031

6.  Effect of myopia on the thickness of the retinal nerve fiber layer measured by Cirrus HD optical coherence tomography.

Authors:  Shin Hee Kang; Seung Woo Hong; Seong Kyu Im; Sang Hyup Lee; Myung Douk Ahn
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-03-17       Impact factor: 4.799

7.  Subfoveal choroidal thickness after treatment of Vogt-Koyanagi-Harada disease.

Authors:  Ichiro Maruko; Tomohiro Iida; Yukinori Sugano; Hiroshi Oyamada; Tetsuju Sekiryu; Takamitsu Fujiwara; Richard F Spaide
Journal:  Retina       Date:  2011-03       Impact factor: 4.256

8.  Risk factors for central serous chorioretinopathy: a case-control study.

Authors:  Robert Haimovici; Sean Koh; David R Gagnon; Todd Lehrfeld; Sarah Wellik
Journal:  Ophthalmology       Date:  2004-02       Impact factor: 12.079

9.  Subclinical keratoconus and inflammatory molecules from tears.

Authors:  I Lema; T Sobrino; J A Durán; D Brea; E Díez-Feijoo
Journal:  Br J Ophthalmol       Date:  2009-03-19       Impact factor: 4.638

10.  The keratoconus corneal proteome: loss of epithelial integrity and stromal degeneration.

Authors:  Raghothama Chaerkady; Hanjuan Shao; Sherri-Gae Scott; Akhilesh Pandey; Albert S Jun; Shukti Chakravarti
Journal:  J Proteomics       Date:  2013-05-29       Impact factor: 4.044

View more
  4 in total

1.  Choroidal thickness assessment in keratoconus patients treated with cross-linking compared to healthy population.

Authors:  Antonio Ballesteros-Sánchez; Concepción De-Hita-Cantalejo; María Carmen Sánchez-González; María-José Bautista-Llamas; José-María Sánchez-González; Beatriz Gargallo-Martínez
Journal:  Int Ophthalmol       Date:  2022-09-23       Impact factor: 2.029

2.  Assessment of the Retinal Vessels in Keratoconus: An OCT Angiography Study.

Authors:  Adam Wylęgała; Dominika Szkodny; Rafał Fiolka; Edward Wylęgała
Journal:  J Clin Med       Date:  2022-05-24       Impact factor: 4.964

3.  The Role of Atopy in the Choroidal Profile of Keratoconus Patients.

Authors:  Ana Filipa Moleiro; Ana Francisca Aires; Hélio Alves; João Viana Pinto; Ângela Carneiro; Fernando Falcão-Reis; Luís Figueira; João Pinheiro-Costa
Journal:  Clin Ophthalmol       Date:  2021-04-28

4.  Increased choroidal thickness is not a disease progression marker in keratoconus.

Authors:  João Pinheiro-Costa; Paulo Jorge Correia; João Viana Pinto; Hélio Alves; Luís Torrão; Raul Moreira; Manuel Falcão; Ângela Carneiro; Maria Dulce Madeira; Fernando Falcão-Reis
Journal:  Sci Rep       Date:  2020-11-17       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.